Disease Vectors: Clinical Trials

4 trials of Disease Vectors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 withdrawn. 3 Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Withdrawn 1
Not applicable1Completed 1
Phase 21Withdrawn 1

Follow Disease Vectors: new trials by email Literature Review of Disease Vectors trials Research Report on Disease Vectors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29
A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.
GRAdHIVNE1 Vaccine, Placebo - HIV
Phase 1RecruitingInternational AIDS Vaccine Initiative1202025-07-282026-02-13
Reading Intervention to Children With Developmental Language Disorder
Grapholearn, Vector, Usual schooling - Developmental Language Disorder
Not applicableCompletedKarolinska Institutet672021-08-012025-12-18
Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Gene Transfer, scAAV2/8-LP1-hFIXco - Hemophilia B
Phase 1CompletedSt. Jude Children's Research Hospital142010-02-222026-04-02

Conditions studied

Charcot-Marie-Tooth Disease (1)  ·  Hemophilia B (1)  ·  Language Development Disorders (1)

Sponsors

International AIDS Vaccine Initiative (1)  ·  Karolinska Institutet (1)  ·  Nationwide Children's Hospital (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (2)  ·  South Africa (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  Zimbabwe (1)

Top investigators

Limakatso Lebina (1)  ·  Nelli Kalnak, PhD (1)  ·  Tariro Makadzange (1)  ·  Theodorah Ndzhukule (1)  ·  Ulrike Reiss, MD (1)  ·  Zarife Sahenk, MD., PhD. (1)

Results publications

PMID 22149959, PMID 25409372, PMID 40499172

NIH funding

R01HL094396 (1)